FY21 Trading Update
Filed with ASX · · 3 pages · English
Story so far
Earlier from Nova Eye Medical
- First Patient enrolled in MAGIC Clinical Trial
- 2RT Post LEAD Review Shows Improved Treatment Benefits
- Clinical trial to Assess Efficacy and Safety of i Track
- Investor presentation Half year Results 31 December 2020
- Half Year Results Discussion
Later from Nova Eye Medical
- FY21 Investor presentation
- Full Year Results FY21
- FY21 Appendix 4E and Annual Report
- Aquisition of Glaucoma Patents
- US Government Stimulus Loan Forgiven
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical